CEO and Co-Founder at Gina Life, a disruptive innovation femtech company developing a platform for early detection in women’s health. With the use of a unique proprietary biomarkers panel supported by AI and data science, a personalized test will be generated for every woman, enabling early detection of women related diseases. Inbal Zafir-Lavie is an experienced leader in the biotechnology and pharma industry (USA and Israel) with excellent scientific skills. Vast experience in leading IND enabling studies, developing CLIA compliant lab tests, performing due diligence for new drugs and technologies, supporting FDA IND and 510(k) submissions. Expert in the fields of gene therapy, molecular immunology, and antibody engineering.